Anti-GBP2 monoclonal antibody

Pre-made anti-GBP2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GBP2/GBP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2881-Ab-1/ GM-Tg-hg-IP2881-Ab-2Anti-Human GBP2 monoclonal antibodyHuman
GM-Tg-rg-IP2881-Ab-1/ GM-Tg-rg-IP2881-Ab-2Anti-Rat GBP2 monoclonal antibodyRat
GM-Tg-mg-IP2881-Ab-1/ GM-Tg-mg-IP2881-Ab-2Anti-Mouse GBP2 monoclonal antibodyMouse
GM-Tg-cynog-IP2881-Ab-1/ GM-Tg-cynog-IP2881-Ab-2Anti-Cynomolgus/ Rhesus macaque GBP2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2881-Ab-1/ GM-Tg-felg-IP2881-Ab-2Anti-Feline GBP2 monoclonal antibodyFeline
GM-Tg-cang-IP2881-Ab-1/ GM-Tg-cang-IP2881-Ab-2Anti-Canine GBP2 monoclonal antibodyCanine
GM-Tg-bovg-IP2881-Ab-1/ GM-Tg-bovg-IP2881-Ab-2Anti-Bovine GBP2 monoclonal antibodyBovine
GM-Tg-equg-IP2881-Ab-1/ GM-Tg-equg-IP2881-Ab-2Anti-Equine GBP2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2881-Ab-1/ GM-Tg-hg-IP2881-Ab-2; GM-Tg-rg-IP2881-Ab-1/ GM-Tg-rg-IP2881-Ab-2;
GM-Tg-mg-IP2881-Ab-1/ GM-Tg-mg-IP2881-Ab-2; GM-Tg-cynog-IP2881-Ab-1/ GM-Tg-cynog-IP2881-Ab-2;
GM-Tg-felg-IP2881-Ab-1/ GM-Tg-felg-IP2881-Ab-2; GM-Tg-cang-IP2881-Ab-1/ GM-Tg-cang-IP2881-Ab-2;
GM-Tg-bovg-IP2881-Ab-1/ GM-Tg-bovg-IP2881-Ab-2; GM-Tg-equg-IP2881-Ab-1/ GM-Tg-equg-IP2881-Ab-2
Products NameAnti-GBP2 monoclonal antibody
Formatmab
Target NameGBP2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GBP2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2881-Ag-1Recombinant multi-species GBP2 protein
    ORF Viral VectorvGMLP001033human GBP2 Lentivirus particle
    ORF Viral VectorpGMLP001033human GBP2 Lentivirus plasmid
    ORF Viral VectorpGMLPm001087mouse Gbp2 Lentivirus plasmid
    ORF Viral VectorvGMLPm001087mouse Gbp2 Lentivirus particle


    Target information

    Target IDGM-IP2881
    Target NameGBP2
    Gene ID2634
    Gene Symbol and SynonymsGBP2
    Uniprot AccessionP32456
    Uniprot Entry NameGBP2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162645
    Target ClassificationN/A

    The target: GBP2, gene name: GBP2, also named as . This gene belongs to the guanine-binding protein (GBP) family, which includes interferon-induced proteins that can bind to guanine nucleotides (GMP, GDP and GTP). The encoded protein is a GTPase which hydrolyzes GTP, predominantly to GDP. The protein may play a role as a marker of squamous cell carcinomas. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.